References
- Girardi M., Heald P. W., Wilson L. D. The pathogenesis of mycosis fungoides. N Engl J Med 2004; 350: 1978–88
- Weinstock M. A., Horm J. W. Mycosis fungoides in the United States: Increasing incidence and descriptive epidemiology. JAMA 1988; 260: 42–6
- Morales Suarez‐Varela M. M., Llopis G. A., Marquina V. A., Bell J. Mycosis fungoides: Review of epidemiological observations. Dermatology 2000; 201: 21–8
- Smoller B. R., Santucci M., Wood G. S., Whittaker S. J. Histopathology and genetics of cutaneous T‐cell lymphoma. Hematol Oncol Clin North Am 2003; 17: 1277–311
- Giuffrida T. J., Kligora C. J., Goldstein G. D. Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg 2004; 30: 1561–4
- Rudisaile S. N., Hurt M. A., Santa Cruz D. J. Granular cell atypical fibroxanthoma. J Cutan Pathol 2005; 32: 314–17
- Ly H., Selva D., James C. L., Huilgol S. C. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma. Australas J Dermatol 2004; 45: 106–9
- Brecher A. Mycosis fungoides. Dermatol Online J 2003; 9: 23
- Koh H. K., Charif M., Weinstock M. A. Epidemiology and clinical manifestations of cutaneous T‐cell lymphoma. Hematol Oncol Clin North Am 1995; 9: 943–60
- Kim Y. H., Hoppe R. T. Mycosis fungoides and the Sézary syndrome. Semin Oncol 1999; 26: 276–89
- Weinstock M. A., Gardstein B. Twenty‐year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 1999; 89: 1240–4
- Shen A., Metz B., Ehrig T., Sinkre P., Hsu S. Capillaritis as a potential harbinger of cutaneous T‐cell lymphoma. Dermatol Online J 2004; 10: 15
- Fitzpatrick T. B., Eisen A. Z., Wolff K., Freedberg I. M., Austen K. F. Dermatology in general medicine. 4th ed. McGraw‐Hill, Inc., New York 1993; 1: 1283–307
- Weedon D. Skin pathology. Churchill Livingstone, New York 1997; 905–9
- Lamberg S. I., Bunn P. A. Proceedings of the workshop on cutaneous T‐cell lymphomas (mycosis fungoides and Sézary syndrome). Cancer Treat Rep 1979; 63: 561–4
- Leong A. S., Milios J. Atypical fibroxanthoma of the skin: A clinicopathological and immunohistochemical study and a discussion of its histogenesis. Histopathology 1987; 11: 463–75
- Seavolt M., McCall M. Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with Mohs Micrographic Surgery. Dermatol Surg 2006; 32: 435–41; discussion 439–41
- Davis J. L., Randle H. W., Zalla M. J., Roenigk R. K., Brodland D. G. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 1997; 23: 105–10
- Huether M., Zitelli J., Brodland D. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 2001; 44: 656–9
- González‐García R., Nam‐Cha S. H., Muñoz‐Guerra M. F., Sastrc‐Pérez J., Rodríguez‐Campo F. J., Naval‐Gías L. Atypical fibroxanthoma of the head and neck: Report of 5 cases. J Oral Maxillofac Surg 2007; 65: 526–31
- Weedon D. Skin pathology. 2nd ed. Elsevier Science, London 2002; 936
- Fletcher C. D. The evolving classification of soft tissue tumours: An update based on the new WHO classification. Histopathology 2006; 48: 3–12
- Dettrick A., Geoff S. Atypical fibroxanthoma with perineural or intraneural invasion: Report of two cases. J Cutan Pathol 2006; 33: 318–22
- Weedon D., Williamson R., Mirza B. CD10, a useful marker for atypical fibroxanthomas. Am J Dermatopathol 2005; 27: 181
- Jensen K., Wilkinson B., Wines N., Kossard S. Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol 2004; 31: 57–61